API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
0
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
1. Pseudo-chelerythrine
2. Pseudochelerythrine
3. Sanguinarin
4. Sanguinarine
5. Sanguinarine Chloride
6. Sanguinarine Hydroxide
7. Sanguinarine Nitrate
8. Sanguinarine Sulfate (1:1)
9. Sanguinarine Sulfate (2:1)
10. Sanguiritrin
11. Sangvinarin
12. Veadent
13. Viadent
1. Sanguinarine Chloride
2. 5578-73-4
3. Viadent
4. Sanguinarine Chloride Hydrate
5. Sanguinarine Hydrochloride
6. Sanguinarine (chloride)
7. [1,3]benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridinium,13-methyl-, Chloride (1:1)
8. Chembl490129
9. 5578-73-4 (chloride)
10. B8z8j4400h
11. Pseudochelerythrine Chloride;sanguinarium Chloride
12. (1,3)benzodioxolo(5,6-c)-1,3-dioxolo(4,5-i)phenanthridinium, 13-methyl-, Chloride
13. 13-methyl-[1,3]dioxolo[4',5':4,5]benzo[1,2-c][1,3]dioxolo[4,5-i]phenanthridin-13-ium Chloride
14. Sanguinarine, Chloride
15. Sanguinarium Chloride [usan:inn]
16. Sanguinarinechloride
17. Pseudochelerythrine Chloride
18. Unii-b8z8j4400h
19. Sr-01000075650
20. Mfcd00012126
21. Chelerythrine Chloride,(s)
22. Schembl43290
23. Hy-n0052a
24. Dtxsid30971158
25. Hms3263m18
26. Sanguinarine Chloride [mi]
27. Sanguinarium Chloride (usan/inn)
28. Sanguinarium Chloride [inn]
29. Sanguinarium Chloride [usan]
30. Tox21_501108
31. Akos024457036
32. Ccg-212462
33. Cs-4784
34. Fd10130
35. Lp01108
36. Ncgc00094379-01
37. Ncgc00094379-02
38. Ncgc00261793-01
39. Ac-34926
40. Ls-14752
41. Db-052796
42. Eu-0101108
43. Ft-0603674
44. D05799
45. S 5890
46. Sanguinarine Chloride Hydrate, >=98% (hplc)
47. Q-100647
48. Sr-01000075650-2
49. Q27274521
50. [1,3]benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridinium, 13-methyl-, Chloride (1:1)
51. 13-methyl-[1,3]-benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridinium Chloride
52. 13-methyl-[1,3]benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i] Phenanthridinium Chloride
53. 13-methyl-2h,10h-[1,3]benzodioxolo[5,6-c][1,3]dioxolo[4,5-i]phenanthridin-13-ium Chloride
54. 24-methyl-5,7,18,20-tetraoxa-24-azoniahexacyclo[11.11.0.0^{2,10.0^{4,8.0^{14,22.0^{17,21]tetracosa-1(24),2,4(8),9,11,13,15,17(21),22-nonaene;chloride
55. 24-methyl-5,7,18,20-tetraoxa-24-azoniahexacyclo[11.11.0.02,10.04,8.014,22.017,21]tetracosa-1(24),2,4(8),9,11,13,15,17(21),22-nonaene;chloride
Molecular Weight | 367.8 g/mol |
---|---|
Molecular Formula | C20H14ClNO4 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 0 |
Exact Mass | 367.0611356 g/mol |
Monoisotopic Mass | 367.0611356 g/mol |
Topological Polar Surface Area | 40.8 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 530 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Cardiotonic Agents
Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)
Anti-Infective Agents
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)